Companies

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) SEC filings

CIK 0001425205 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2021
Revenue (USD)263.5 M
Net income (USD)-259.6 M-197.6 M
Diluted EPS (USD/shares)-1.09-2.49

Latest filings

FiledFormDescriptionPeriod
2026-10-058-KFORM 8-K items 8.01,9.012026-10-05
2026-10-024OWNERSHIP DOCUMENT2026-09-30
2026-10-023OWNERSHIP DOCUMENT2026-09-30
2026-09-298-KFORM 8-K items 8.01,9.012026-09-29
2026-09-104OWNERSHIP DOCUMENT2026-09-08
2026-09-104OWNERSHIP DOCUMENT2026-09-08
2026-09-104OWNERSHIP DOCUMENT2026-09-08
2026-09-034OWNERSHIP DOCUMENT2026-09-01
2026-09-034OWNERSHIP DOCUMENT2026-09-01
2026-09-034OWNERSHIP DOCUMENT2026-09-01
2026-08-124OWNERSHIP DOCUMENT2026-08-10
2026-08-104OWNERSHIP DOCUMENT2026-08-06
2026-08-07SCHEDULE 13GSCHEDULE 13G
2026-08-068-KFORM 8-K items 8.01,9.012026-08-06
2026-08-0610-Q10-Q2026-06-30
2026-08-068-KFORM 8-K items 2.02,9.012026-08-06
2026-07-28SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-028-KFORM 8-K items 8.01,9.012026-06-30
2026-06-184OWNERSHIP DOCUMENT2026-06-16
2026-06-184OWNERSHIP DOCUMENT2026-06-16
2026-06-184OWNERSHIP DOCUMENT2026-06-16
2026-06-184OWNERSHIP DOCUMENT2026-06-16
2026-06-184OWNERSHIP DOCUMENT2026-06-16
2026-06-18S-8FORM S-8
2026-06-18S-8FORM S-8

Forms on file (last 1,000): 4 293, 8-K 244, SC 13G/A 58, 10-Q 48, 3 40, SC 13G 29, 424B5 21, CORRESP 21. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=IOVA (0.002 USD), /gw/filings/filings?ticker=IOVA&form=8-K, /gw/filings/facts?ticker=IOVA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange